TGTX-112

N/A

Report date: 2024/11/07 16:30:28

Base Information

Drug NameTGTX-112
Drug Alias NameTSHA-112TGTX-112
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of Action1,4-alpha-glucan-branching enzyme modulators
Targets1,4-alpha-glucan-branching enzyme
Therapy Area/IndicationsPolyglucosan Body Disease, Adult Form
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesTaysha Gene Therapies Inc
Inactive CompaniesN/A
Active IndicationsPolyglucosan Body Disease, Adult Form
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A